Stem Cell Therapy in Las Vegas: Evidence & FDA Status
Stem-cell research includes approved treatments for specific diseases and investigational products. These categories are not interchangeable. This guide explains the regulatory distinctions and questions to ask; it is not an offer of placental-derived stem-cell infusions.
LiveNow Longevity ·
What are stem-cell products?
Stem cells are living cells. Products differ by cell source, processing, composition, route of administration and intended use. Donor-derived and a person’s own cells are not interchangeable, and a product described as placental tissue should not automatically be assumed to contain viable stem cells.
For patients researching joint pain, injury recovery or healthy aging, the useful question is whether the exact proposed product has evidence and a lawful pathway for that use. Evidence from a different cell product or disease cannot establish that an IV infusion will repair joints or reverse aging.
Which stem-cell treatments have FDA approval?
The claim that only cord-blood stem-cell products have FDA approval is outdated. FDA approved Ryoncil, a bone-marrow-derived mesenchymal stromal cell therapy, in December 2024 for steroid-refractory acute graft-versus-host disease in children aged two months and older. That specific approval does not establish approval for joint pain, general recovery or longevity.
Check FDA’s current approved cellular and gene therapy product list and the exact product label. We do not advertise an approved placental-derived IV treatment for anti-aging, pain or orthopedic conditions on this page.
Risks and investigational access
FDA has received reports of infections, unwanted immune reactions, tumor formation and other serious harms associated with unapproved regenerative products. These reports do not establish the risk rate of every product, and physician supervision does not remove product-specific uncertainty.
For an investigational product, ask the study team for the FDA investigational authorization information and study consent materials. A listing on ClinicalTrials.gov or a supplier’s FDA registration is not authorization to sell a treatment. State provisions do not replace applicable federal requirements.
Cost and medical assessment
There is no stem-cell infusion price or treatment-booking offer on this page. A fee for a general medical assessment is separate from the price or availability of any investigational product. An assessment can address symptoms, existing diagnoses, evidence, alternatives and appropriate referrals; it cannot make an otherwise unavailable product lawful.
Before any elective care, confirm what an evaluation includes, which tests are necessary, who charges for them and the expected follow-up costs. A recommendation may be standard care, specialist referral or no additional intervention.
Common Questions
Do you offer stem-cell therapy through this page?
No. This page provides educational information and does not offer or arrange stem-cell infusions. It should not be used as confirmation that a product is available at LiveNow.
Are stem cells and exosomes the same?
No. Stem cells are living cells; exosomes are cell-released vesicles. Their composition, evidence and regulatory requirements differ. Approval of one cellular product does not approve exosome products.
Can stem cells reverse aging or fix joint pain?
No such outcome is promised here. Product-specific human evidence and regulatory status must be evaluated for the proposed condition; results from unrelated products or laboratory research cannot establish a clinical benefit.
Does physician supervision or informed consent establish legal access?
No. Consent, physician supervision, a supplier certificate or state permission does not establish that a particular product may be marketed under federal law. The exact product, intended use and applicable regulatory pathway matter.
What should I ask before paying for a proposed treatment?
Ask for the exact product and manufacturer, the proposed route and use, its FDA approval or applicable investigational authorization, the human evidence, material risks, alternatives and a written itemized cost estimate. Trial registration alone is not FDA approval.
General educational information. An individual medical assessment and the exact product’s regulatory status are separate from this guide.